annual working capital:
$161.18M+$167.75M(+2555.93%)Summary
- As of today (September 18, 2025), CDTX annual working capital is $161.18 million, with the most recent change of +$167.75 million (+2555.93%) on December 31, 2024.
- During the last 3 years, CDTX annual working capital has risen by +$123.50 million (+327.76%).
- CDTX annual working capital is now at all-time high.
Performance
CDTX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$499.47M+$359.43M(+256.67%)Summary
- As of today (September 18, 2025), CDTX quarterly working capital is $499.47 million, with the most recent change of +$359.43 million (+256.67%) on June 30, 2025.
- Over the past year, CDTX quarterly working capital has increased by +$370.53 million (+287.35%).
- CDTX quarterly working capital is now at all-time high.
Performance
CDTX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
CDTX Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2555.9% | +287.4% |
| 3 y3 years | +327.8% | +9710.9% |
| 5 y5 years | +352.6% | +1198.3% |
CDTX Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2555.9% | at high | +2786.6% |
| 5 y | 5-year | at high | +2555.9% | at high | +2786.6% |
| alltime | all time | at high | +2555.9% | at high | +2786.6% |
CDTX Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $499.47M(+256.7%) |
| Mar 2025 | - | $140.04M(-13.1%) |
| Dec 2024 | $161.18M(-2555.9%) | $161.18M(+43.4%) |
| Sep 2024 | - | $112.43M(-12.8%) |
| Jun 2024 | - | $128.94M(-793.6%) |
| Mar 2024 | - | -$18.59M(+183.3%) |
| Dec 2023 | -$6.56M(-277.7%) | -$6.56M(-129.7%) |
| Sep 2023 | - | $22.08M(-28.3%) |
| Jun 2023 | - | $30.82M(-29.7%) |
| Mar 2023 | - | $43.83M(+1086.4%) |
| Dec 2022 | $3.69M(-90.2%) | $3.69M(-88.0%) |
| Sep 2022 | - | $30.85M(+506.0%) |
| Jun 2022 | - | $5.09M(-74.4%) |
| Mar 2022 | - | $19.90M(-47.2%) |
| Dec 2021 | $37.68M(+102.3%) | $37.68M(+173.3%) |
| Sep 2021 | - | $13.79M(-49.3%) |
| Jun 2021 | - | $27.19M(+139.9%) |
| Mar 2021 | - | $11.34M(-39.1%) |
| Dec 2020 | $18.63M(-47.7%) | $18.63M(-29.2%) |
| Sep 2020 | - | $26.32M(-31.6%) |
| Jun 2020 | - | $38.47M(-24.6%) |
| Mar 2020 | - | $50.99M(+43.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $35.62M(-37.8%) | $35.62M(-22.4%) |
| Sep 2019 | - | $45.91M(+57.6%) |
| Jun 2019 | - | $29.14M(-29.6%) |
| Mar 2019 | - | $41.38M(-27.7%) |
| Dec 2018 | $57.24M(-12.7%) | $57.24M(-27.0%) |
| Sep 2018 | - | $78.40M(-13.9%) |
| Jun 2018 | - | $91.08M(+58.5%) |
| Mar 2018 | - | $57.47M(-12.4%) |
| Dec 2017 | $65.58M(-32.0%) | $65.58M(+13.9%) |
| Sep 2017 | - | $57.59M(-16.7%) |
| Jun 2017 | - | $69.14M(-18.1%) |
| Mar 2017 | - | $84.39M(-12.5%) |
| Dec 2016 | $96.49M(-5.6%) | $96.49M(+33.4%) |
| Sep 2016 | - | $72.35M(-12.9%) |
| Jun 2016 | - | $83.11M(-11.1%) |
| Mar 2016 | - | $93.46M(-8.6%) |
| Dec 2015 | $102.24M(+416.4%) | $102.24M(-8.0%) |
| Sep 2015 | - | $111.09M(-7.4%) |
| Jun 2015 | - | $119.98M(+119.8%) |
| Mar 2015 | - | $54.59M(+175.7%) |
| Dec 2014 | $19.80M(>+9900.0%) | $19.80M |
| Dec 2013 | $82.00K | - |
FAQ
- What is Cidara Therapeutics, Inc. annual working capital?
- What is the all time high annual working capital for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual working capital year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly working capital?
- What is the all time high quarterly working capital for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly working capital year-on-year change?
What is Cidara Therapeutics, Inc. annual working capital?
The current annual working capital of CDTX is $161.18M
What is the all time high annual working capital for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual working capital is $161.18M
What is Cidara Therapeutics, Inc. annual working capital year-on-year change?
Over the past year, CDTX annual working capital has changed by +$167.75M (+2555.93%)
What is Cidara Therapeutics, Inc. quarterly working capital?
The current quarterly working capital of CDTX is $499.47M
What is the all time high quarterly working capital for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly working capital is $499.47M
What is Cidara Therapeutics, Inc. quarterly working capital year-on-year change?
Over the past year, CDTX quarterly working capital has changed by +$370.53M (+287.35%)